TW201216859A - Disinfectant and antiseptic formulation having reduced iodine content - Google Patents

Disinfectant and antiseptic formulation having reduced iodine content Download PDF

Info

Publication number: TW201216859A
Authority: TW; Taiwan
Prior art keywords: formulation; iodine; weight; mixture; agent
Prior art date: 2010-07-12

Application number

TW100124147A

Other languages

English (en)

Chinese (zh)

Inventor

Endre Mikulasik

Tamas Spaits

Original Assignee

Egis Gyogyszergyar Nylvanosan Mukodo Reszvenytarsasag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-07-12

Filing date

2011-07-08

Publication date

2012-05-01

2011-07-08 Application filed by Egis Gyogyszergyar Nylvanosan Mukodo Reszvenytarsasag filed Critical Egis Gyogyszergyar Nylvanosan Mukodo Reszvenytarsasag

2012-05-01 Publication of TW201216859A publication Critical patent/TW201216859A/zh

Links

239000000203 mixture Substances 0.000 title claims abstract description 85
238000009472 formulation Methods 0.000 title claims abstract description 60
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 title claims abstract description 57
239000011630 iodine Substances 0.000 title claims abstract description 57
229910052740 iodine Inorganic materials 0.000 title claims abstract description 57
230000002421 anti-septic effect Effects 0.000 title claims abstract description 15
239000000645 desinfectant Substances 0.000 title claims abstract description 14
239000002904 solvent Substances 0.000 claims abstract description 13
239000003795 chemical substances by application Substances 0.000 claims abstract description 10
239000003755 preservative agent Substances 0.000 claims description 14
230000002335 preservative effect Effects 0.000 claims description 11
230000000249 desinfective effect Effects 0.000 claims description 9
239000000546 pharmaceutical excipient Substances 0.000 claims description 9
229920001971 elastomer Polymers 0.000 claims description 8
239000000443 aerosol Substances 0.000 claims description 7
239000003921 oil Substances 0.000 claims description 7
150000001875 compounds Chemical class 0.000 claims description 6
-1 hexamethylene dioxane Chemical compound 0.000 claims description 6
238000000034 method Methods 0.000 claims description 6
239000004480 active ingredient Substances 0.000 claims description 5
230000006378 damage Effects 0.000 claims description 5
239000007788 liquid Substances 0.000 claims description 5
239000008194 pharmaceutical composition Substances 0.000 claims description 5
239000004575 stone Substances 0.000 claims description 5
239000013543 active substance Substances 0.000 claims description 4
239000002537 cosmetic Substances 0.000 claims description 4
239000000806 elastomer Substances 0.000 claims description 4
239000006071 cream Substances 0.000 claims description 3
239000006260 foam Substances 0.000 claims description 3
239000001301 oxygen Substances 0.000 claims description 3
229910052760 oxygen Inorganic materials 0.000 claims description 3
230000008901 benefit Effects 0.000 claims description 2
238000004519 manufacturing process Methods 0.000 claims description 2
230000001737 promoting effect Effects 0.000 claims description 2
AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims 2
239000004615 ingredient Substances 0.000 claims 2
FCTMFTCHMVUGTA-UHFFFAOYSA-N 2,3,4,4a-tetrahydrocyclopenta[b]pyran Chemical compound O1C=2C(CCC1)C=CC=2 FCTMFTCHMVUGTA-UHFFFAOYSA-N 0.000 claims 1
YPZLBXPMVVDZOP-UHFFFAOYSA-N 4-methyltrioxane Chemical compound CC1OOOCC1 YPZLBXPMVVDZOP-UHFFFAOYSA-N 0.000 claims 1
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims 1
DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
230000003115 biocidal effect Effects 0.000 claims 1
229940008099 dimethicone Drugs 0.000 claims 1
239000004205 dimethyl polysiloxane Substances 0.000 claims 1
235000013870 dimethyl polysiloxane Nutrition 0.000 claims 1
239000000825 pharmaceutical preparation Substances 0.000 claims 1
IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 claims 1
229920000435 poly(dimethylsiloxane) Polymers 0.000 claims 1
230000001172 regenerating effect Effects 0.000 claims 1
235000011149 sulphuric acid Nutrition 0.000 claims 1
239000001117 sulphuric acid Substances 0.000 claims 1
230000029663 wound healing Effects 0.000 claims 1
125000005375 organosiloxane group Chemical group 0.000 abstract 1
239000000243 solution Substances 0.000 description 33
238000012360 testing method Methods 0.000 description 17
238000004659 sterilization and disinfection Methods 0.000 description 13
OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 10
208000027418 Wounds and injury Diseases 0.000 description 7
238000006116 polymerization reaction Methods 0.000 description 7
238000002360 preparation method Methods 0.000 description 7
206010052428 Wound Diseases 0.000 description 6
238000011282 treatment Methods 0.000 description 6
241000894006 Bacteria Species 0.000 description 5
230000000844 anti-bacterial effect Effects 0.000 description 5
238000011534 incubation Methods 0.000 description 5
150000002500 ions Chemical class 0.000 description 5
239000002609 medium Substances 0.000 description 5
230000000451 tissue damage Effects 0.000 description 5
231100000827 tissue damage Toxicity 0.000 description 5
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
206010036790 Productive cough Diseases 0.000 description 4
241000700605 Viruses Species 0.000 description 4
230000000694 effects Effects 0.000 description 4
238000001704 evaporation Methods 0.000 description 4
230000007794 irritation Effects 0.000 description 4
244000005700 microbiome Species 0.000 description 4
238000004321 preservation Methods 0.000 description 4
239000005060 rubber Substances 0.000 description 4
239000007787 solid Substances 0.000 description 4
210000003802 sputum Anatomy 0.000 description 4
208000024794 sputum Diseases 0.000 description 4
KZRXTDVKMJQCBB-UHFFFAOYSA-N 4-octadecyltrioxane Chemical compound C(CCCCCCCCCCCCCCCCC)C1OOOCC1 KZRXTDVKMJQCBB-UHFFFAOYSA-N 0.000 description 3
UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 3
MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
241000233866 Fungi Species 0.000 description 3
230000009471 action Effects 0.000 description 3
230000001580 bacterial effect Effects 0.000 description 3
230000008020 evaporation Effects 0.000 description 3
239000007789 gas Substances 0.000 description 3
239000000499 gel Substances 0.000 description 3
230000007774 longterm Effects 0.000 description 3
238000003756 stirring Methods 0.000 description 3
KDTWXGUXWNBYGS-UHFFFAOYSA-N 1,2,3,3,4,4-hexamethyl-5H-diazepine Chemical group CC1(C(N(N(C=CC1)C)C)(C)C)C KDTWXGUXWNBYGS-UHFFFAOYSA-N 0.000 description 2
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
241000222120 Candida <Saccharomycetales> Species 0.000 description 2
206010012735 Diarrhoea Diseases 0.000 description 2
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
241000191967 Staphylococcus aureus Species 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
230000003385 bacteriostatic effect Effects 0.000 description 2
238000011109 contamination Methods 0.000 description 2
238000005260 corrosion Methods 0.000 description 2
238000000354 decomposition reaction Methods 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
238000011049 filling Methods 0.000 description 2
230000012010 growth Effects 0.000 description 2
229920006158 high molecular weight polymer Polymers 0.000 description 2
FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
239000012528 membrane Substances 0.000 description 2
244000052769 pathogen Species 0.000 description 2
230000035699 permeability Effects 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
150000003304 ruthenium compounds Chemical class 0.000 description 2
230000035945 sensitivity Effects 0.000 description 2
238000003860 storage Methods 0.000 description 2
229910052712 strontium Inorganic materials 0.000 description 2
CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
239000000829 suppository Substances 0.000 description 2
ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
WLRWTEIAYJHXDW-UHFFFAOYSA-N 2,2,3,3,4,4,4a,5,5,6-decamethyl-6H-cyclopenta[b]pyran Chemical compound CC1C=C2C(C(C(C(O2)(C)C)(C)C)(C)C)(C1(C)C)C WLRWTEIAYJHXDW-UHFFFAOYSA-N 0.000 description 1
VPEQRDHARPHTHO-UHFFFAOYSA-N 2-decyloxane Chemical compound CCCCCCCCCCC1CCCCO1 VPEQRDHARPHTHO-UHFFFAOYSA-N 0.000 description 1
SZWGQJGDDHOUKJ-UHFFFAOYSA-N 2-octadecyl-1,4-dioxane Chemical compound CCCCCCCCCCCCCCCCCCC1COCCO1 SZWGQJGDDHOUKJ-UHFFFAOYSA-N 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
206010002383 Angina Pectoris Diseases 0.000 description 1
244000063299 Bacillus subtilis Species 0.000 description 1
235000014469 Bacillus subtilis Nutrition 0.000 description 1
239000004484 Briquette Substances 0.000 description 1
244000025254 Cannabis sativa Species 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
229920000742 Cotton Polymers 0.000 description 1
241000588724 Escherichia coli Species 0.000 description 1
208000010201 Exanthema Diseases 0.000 description 1
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
206010020751 Hypersensitivity Diseases 0.000 description 1
UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
DKNPRRRKHAEUMW-UHFFFAOYSA-N Iodine aqueous Chemical compound [K+].I[I-]I DKNPRRRKHAEUMW-UHFFFAOYSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
229930182764 Polyoxin Natural products 0.000 description 1
229920002675 Polyoxyl Polymers 0.000 description 1
229920000153 Povidone-iodine Polymers 0.000 description 1
241000589517 Pseudomonas aeruginosa Species 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
206010057040 Temperature intolerance Diseases 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
239000002253 acid Substances 0.000 description 1
238000001467 acupuncture Methods 0.000 description 1
239000008272 agar Substances 0.000 description 1
238000013019 agitation Methods 0.000 description 1
208000026935 allergic disease Diseases 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000675 anti-caries Effects 0.000 description 1
230000003260 anti-sepsis Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
229940121375 antifungal agent Drugs 0.000 description 1
239000003443 antiviral agent Substances 0.000 description 1
229940121357 antivirals Drugs 0.000 description 1
150000001540 azides Chemical class 0.000 description 1
229940064804 betadine Drugs 0.000 description 1
229910052797 bismuth Inorganic materials 0.000 description 1
JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
238000009835 boiling Methods 0.000 description 1
244000309464 bull Species 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical group OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
238000002485 combustion reaction Methods 0.000 description 1
125000004122 cyclic group Chemical group 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
238000010586 diagram Methods 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
239000000539 dimer Substances 0.000 description 1
238000006471 dimerization reaction Methods 0.000 description 1
AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
238000002845 discoloration Methods 0.000 description 1
239000002270 dispersing agent Substances 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
238000004821 distillation Methods 0.000 description 1
239000003651 drinking water Substances 0.000 description 1
235000020188 drinking water Nutrition 0.000 description 1
239000003814 drug Substances 0.000 description 1
238000004043 dyeing Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
201000005884 exanthem Diseases 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000005187 foaming Methods 0.000 description 1
239000012737 fresh medium Substances 0.000 description 1
235000013882 gravy Nutrition 0.000 description 1
229910052736 halogen Inorganic materials 0.000 description 1
150000002367 halogens Chemical class 0.000 description 1
239000000383 hazardous chemical Substances 0.000 description 1
239000013003 healing agent Substances 0.000 description 1
230000005802 health problem Effects 0.000 description 1
230000008543 heat sensitivity Effects 0.000 description 1
239000001307 helium Substances 0.000 description 1
229910052734 helium Inorganic materials 0.000 description 1
SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
238000000265 homogenisation Methods 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000002209 hydrophobic effect Effects 0.000 description 1
230000009610 hypersensitivity Effects 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
238000009776 industrial production Methods 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
150000002496 iodine Chemical class 0.000 description 1
239000003446 ligand Substances 0.000 description 1
239000012669 liquid formulation Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
230000005923 long-lasting effect Effects 0.000 description 1
239000002932 luster Substances 0.000 description 1
239000000463 material Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
239000013028 medium composition Substances 0.000 description 1
239000000178 monomer Substances 0.000 description 1
210000000214 mouth Anatomy 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
230000003472 neutralizing effect Effects 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
239000002674 ointment Substances 0.000 description 1
150000002894 organic compounds Chemical class 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
150000002923 oximes Chemical class 0.000 description 1
239000005022 packaging material Substances 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000001717 pathogenic effect Effects 0.000 description 1
239000008188 pellet Substances 0.000 description 1
229940124531 pharmaceutical excipient Drugs 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
239000004033 plastic Substances 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
239000002798 polar solvent Substances 0.000 description 1
229920000747 poly(lactic acid) Polymers 0.000 description 1
229920002098 polyfluorene Polymers 0.000 description 1
229920000151 polyglycol Polymers 0.000 description 1
239000010695 polyglycol Substances 0.000 description 1
239000004626 polylactic acid Substances 0.000 description 1
YEBIHIICWDDQOL-YBHNRIQQSA-N polyoxin Polymers O[C@@H]1[C@H](O)[C@@H](C(C=O)N)O[C@H]1N1C(=O)NC(=O)C(C(O)=O)=C1 YEBIHIICWDDQOL-YBHNRIQQSA-N 0.000 description 1
229920001021 polysulfide Polymers 0.000 description 1
239000005077 polysulfide Substances 0.000 description 1
150000008117 polysulfides Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
239000013641 positive control Substances 0.000 description 1
229940069328 povidone Drugs 0.000 description 1
239000000843 powder Substances 0.000 description 1
230000008569 process Effects 0.000 description 1
238000012545 processing Methods 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
206010037844 rash Diseases 0.000 description 1
238000012827 research and development Methods 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
229920006395 saturated elastomer Polymers 0.000 description 1
230000035807 sensation Effects 0.000 description 1
230000001568 sexual effect Effects 0.000 description 1
230000036555 skin type Effects 0.000 description 1
239000000779 smoke Substances 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
239000001593 sorbitan monooleate Substances 0.000 description 1
229940035049 sorbitan monooleate Drugs 0.000 description 1
235000011069 sorbitan monooleate Nutrition 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
239000000126 substance Substances 0.000 description 1
229910021653 sulphate ion Inorganic materials 0.000 description 1
230000009469 supplementation Effects 0.000 description 1
238000013268 sustained release Methods 0.000 description 1
239000012730 sustained-release form Substances 0.000 description 1
238000010998 test method Methods 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
230000017423 tissue regeneration Effects 0.000 description 1
230000000699 topical effect Effects 0.000 description 1
231100000167 toxic agent Toxicity 0.000 description 1
239000003440 toxic substance Substances 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000003612 virological effect Effects 0.000 description 1
238000005406 washing Methods 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N59/00—Biocides, pest repellants or attractants, or plant growth regulators containing elements or inorganic compounds
- A01N59/12—Iodine, e.g. iodophors; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/695—Silicon compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/20—Halogens; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
- A61K8/585—Organosilicon compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Inorganic Chemistry (AREA)
Birds (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Dentistry (AREA)
Plant Pathology (AREA)
Pest Control & Pesticides (AREA)
Agronomy & Crop Science (AREA)
Environmental Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Cleaning By Liquid Or Steam (AREA)

TW100124147A 2010-07-12 2011-07-08 Disinfectant and antiseptic formulation having reduced iodine content TW201216859A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
HU1000362A HUP1000362A2 (en)	2010-07-12	2010-07-12	Antiseptic and disinfecting compositions having reduced iodine content

Publications (1)

Publication Number	Publication Date
TW201216859A true TW201216859A (en)	2012-05-01

Family

ID=89989820

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW100124147A TW201216859A (en)	2010-07-12	2011-07-08	Disinfectant and antiseptic formulation having reduced iodine content

Country Status (11)

Country	Link
EP (1)	EP2592935A2 (fr)
AR (1)	AR082155A1 (fr)
BR (1)	BR112013000690A2 (fr)
EA (1)	EA022847B1 (fr)
GE (1)	GEP20156236B (fr)
HK (1)	HK1150373A2 (fr)
HU (1)	HUP1000362A2 (fr)
TW (1)	TW201216859A (fr)
UA (1)	UA109144C2 (fr)
UY (1)	UY33502A (fr)
WO (1)	WO2012007776A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2012150891A1 (fr) *	2011-05-02	2012-11-08	Lipidor Ab	Composition destinée à l'administration d'un agent pharmacologiquement ou cosmétiquement actif sur une surface d'un organisme vivant
GB2521997A (en)	2013-09-06	2015-07-15	Biocompatibles Uk Ltd	Radiopaque polymers
WO2016175728A1 (fr) *	2015-04-27	2016-11-03	Aydin Kimya Sanayi Ve Ticaret Anonim Sirketi	Procédé de production d'une solution antimicrobienne à base de pdms-i
WO2016209966A1 (fr)	2015-06-22	2016-12-29	Infection Containment Company, LLC	Système antiseptique topique
CN110403923B (zh)	2015-09-30	2021-09-21	诺瓦利克有限责任公司	半氟化化合物和其组合物
CA3058097C (fr)	2017-04-21	2024-01-02	Novaliq Gmbh	Compositions d'iode
MX2020003534A (es)	2017-09-27	2020-07-29	Novaliq Gmbh	Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.
CA3111870C (fr)	2018-09-27	2022-04-12	Novaliq Gmbh	Formulation d'ecran solaire topique
EP3856124A1 (fr)	2018-09-27	2021-08-04	Novaliq GmbH	Réparation de la barrière lipidique
CN112755050B (zh) *	2020-12-31	2022-11-15	佛山市正典生物技术有限公司	一种具有高组分稳定性的不含醇含碘消毒剂及其制备方法
CN114208818B (zh) *	2021-11-09	2022-10-04	佛山市正典生物技术有限公司	包含多元醇醚和/或环醚的含碘消毒剂及制备方法
EP4444371A4 (fr) *	2021-12-09	2025-12-03	I2Pure Corp	Polymères à infusion d'iode moléculaire, articles, produits et leur préparation et utilisation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3081232A (en) *	1960-12-27	1963-03-12	Warner Lambert Pharmaceutical	Iodine preparation and method of disinfecting the skin
US4384960A (en)	1979-11-13	1983-05-24	Polley R D	Iodine dispenser and method of dispensing iodine
US4678663A (en) *	1984-02-06	1987-07-07	Nuetrogena Corporation	Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
FR2611734B1 (fr)	1987-02-26	1989-06-16	Rhone Poulenc Chimie	Composition elastomere silicone polycondensation contenant de l'iode pour le traitement des eaux
FR2611735B1 (fr)	1987-02-26	1989-06-16	Rhone Poulenc Chimie	Composition elastomere silicone polyaddition contenant de l'iode pour le traitement de l'eau
FR2611733B1 (fr)	1987-02-26	1989-06-16	Rhone Poulenc Chimie	Composition a base de gomme diorganopolysiloxane contenant de l'iode pour le traitement des eaux
FR2634772A1 (fr)	1988-07-29	1990-02-02	Rhone Poulenc Chimie	Composition a base d'huile diorganopolysiloxane contenant de l'iode pour le traitement des eaux
FR2648143B1 (fr)	1989-06-08	1991-09-06	Rhone Poulenc Chimie	Composition comprenant un copolymere silicone thermoplastique et un compose de l'iode, utilisable apres sa mise en forme, pour le traitement des eaux
US6024968A (en) *	1991-08-16	2000-02-15	Lincoln Technologies Inc.	Intersorption composition and method
DE19837850C1 (de)	1998-08-20	2000-01-05	Wacker Chemie Gmbh	Mischungen flüchtiger linearer Siloxane, Verfahren zu ihrer Herstellung sowie diese enthaltenden kosmetischen Formulierungen
JP2006083119A (ja) *	2004-09-17	2006-03-30	Mandom Corp	殺菌消毒剤組成物
WO2006138035A1 (fr) *	2005-06-13	2006-12-28	Dow Corning Corporation	Vehicule pour l'administration d'agents pharmaceutiques solubles lipidiques topiques
CA2618993A1 (fr) *	2005-08-13	2007-02-22	Collegium Pharmaceutical, Inc.	Administration topique a l'aide d'un fluide porteur

2010
- 2010-07-12 HU HU1000362A patent/HUP1000362A2/hu unknown
2011
- 2011-07-08 TW TW100124147A patent/TW201216859A/zh unknown
- 2011-07-11 UY UY0001033502A patent/UY33502A/es not_active Application Discontinuation
- 2011-07-12 BR BR112013000690A patent/BR112013000690A2/pt not_active IP Right Cessation
- 2011-07-12 GE GEAP201112995A patent/GEP20156236B/en unknown
- 2011-07-12 EP EP11751629.4A patent/EP2592935A2/fr not_active Withdrawn
- 2011-07-12 UA UAA201301371A patent/UA109144C2/ru unknown
- 2011-07-12 AR ARP110102499A patent/AR082155A1/es unknown
- 2011-07-12 WO PCT/HU2011/000065 patent/WO2012007776A2/fr not_active Ceased
- 2011-07-12 HK HK11107198.2A patent/HK1150373A2/xx not_active IP Right Cessation
- 2011-07-12 EA EA201390090A patent/EA022847B1/ru not_active IP Right Cessation

Also Published As

Publication number	Publication date
WO2012007776A3 (fr)	2012-06-07
GEP20156236B (en)	2015-01-26
HK1150373A2 (en)	2011-12-16
UA109144C2 (ru)	2015-07-27
EA201390090A1 (ru)	2013-05-30
WO2012007776A2 (fr)	2012-01-19
HU1000362D0 (en)	2010-10-28
EP2592935A2 (fr)	2013-05-22
BR112013000690A2 (pt)	2016-05-17
HUP1000362A2 (en)	2012-11-28
AR082155A1 (es)	2012-11-14
EA022847B1 (ru)	2016-03-31
UY33502A (es)	2012-01-31

Publication	Publication Date	Title
TW201216859A (en)	2012-05-01	Disinfectant and antiseptic formulation having reduced iodine content
US11471481B2 (en)	2022-10-18	Rapid-deposition thin-film forming compositions as effective wound care treatment
Osmanov et al.	2020	The antiseptic Miramistin: a review of its comparative in vitro and clinical activity
CN103356738B (zh)	2015-05-20	一种皮肤消毒凝胶及其应用
CN109316536A (zh)	2019-02-12	一种皮肤黏膜消毒剂及其制备方法
KR102799949B1 (ko)	2025-04-23	세척, 소독, 멸균 및/또는 치료를 위한 조성물, 키트, 방법 및 용도
US20150264935A1 (en)	2015-09-24	Semi-Fluidic Composition for Lubricating, Moisture Retaining, Disinfecting, Sterilizing and Method Using the Same
CN105055642A (zh)	2015-11-18	一种复方胍类消毒剂及其制备方法
CN105031609B (zh)	2018-10-12	含抗菌肽Cbf-14的消毒剂及其制备和用途
CN110917196B (zh)	2020-06-05	一种氯喹抑菌消毒液及其应用
CN105055304A (zh)	2015-11-18	一种含复合杀菌成份的免洗护肤消毒凝胶及其制备方法
CN106818837B (zh)	2019-07-05	生物抗菌多肽制剂、制备方法及其应用
CN113631155A (zh)	2021-11-09	消毒剂组合物、其制备方法和用途
CN101491245B (zh)	2012-06-27	一种含林蛙抗菌肽的消毒制剂及其制备方法和应用
CN112999331A (zh)	2021-06-22	一种生物杀菌制剂的制备方法和应用
CN111700910A (zh)	2020-09-25	一种避免人感染动物病菌的清洗消毒液
CN104287979A (zh)	2015-01-21	一种含载银介孔硅免洗抗菌洗手液及其制备方法
CN112999202A (zh)	2021-06-22	抗菌除臭的成膜喷液及其制备方法
CN111500490A (zh)	2020-08-07	一种微生物型抑菌去味制剂及其制备方法和应用
CN107753489B (zh)	2020-06-05	一种脚气制剂及其制备方法
KR102267156B1 (ko)	2021-06-21	살균 및 소독용 조성물 및 그 제조방법
CN111920911B (zh)	2022-02-25	一种防蚊消毒剂及制备方法
RU2203035C1 (ru)	2003-04-27	Фармацевтическая композиция с дезинфицирующими, спороцидными и ранозаживляющими свойствами
JP2786634B2 (ja)	1998-08-13	医薬組成物
CN100431419C (zh)	2008-11-12	一种用于足部消毒的生物制剂